Jan 29 (Reuters) - A U.S. district judge on Thursday dismissed a lawsuit ‌alleging ​Johnson & Johnson committed fraud by ...

THOMASVILLE, Ga. (WALB) - A Thomas County judge has denied a plea deal that would have allowed a man accused of molesting a ...

Florida and Utah have banned fluoridation, with multiple other states looking to do the same. Critics of fluoride in drinking water point to supplements as an alternative, but many are creating ...

See it! Get the Nike V2K Running Sneakers for just $90 (originally $125) at DSW! We love these comfy sneakers because they combine bold metallic hues with neutral plastic details that offer unique ...

The Denver Nuggets sit third in the Western Conference at 21-8, but their depth will be put to the test once again after seeing starting forward Cam Johnson suffer a knee injury. Johnson sustained a ...

There isn’t a timetable for his return but Cameron Johnson is expected to miss a few games. ARNIE MELENDREZ STAPLETON | The Associated Press Cameron Johnson got hurt early in the fourth quarter of ...

The $1.5 billion jury award follows a talc verdict on Friday of $65.5 million against Johnson & Johnson in Minnesota. Dean Omar, the firm that won the verdict, also got a $966 million talc award ...

Mayor Brandon Johnson announced Tuesday he will not veto the 2026 budget passed by aldermen, conceding a historic struggle that reached the brink of a government shutdown and burned his goodwill with ...

Josh Johnson is the Ryan Fitzpatrick of Josh McCowns. By which, I mean, he's a king among journeymen. His action in service of an injured Marcus Mariota in Week 16 marked his first pass as a member of ...

ST. PAUL, Minn. — A Minnesota jury awarded $65.5 million on Friday to a mother of three who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing ...

Plaintiff Anna Carley alleged that her lifetime exposure to asbestos-containing cosmetic talc products, including Johnson & Johnson’s baby powder, caused her to mesothelioma diagnosis. The verdict, ...

Johnson & Johnson is rated a buy, with accelerating revenue and earnings growth driven by TREMFYA, CARVYKTI, and robust MedTech innovation. JNJ's portfolio reshaping (divesting Orthopaedics and ...